Please read the guidelines in full before submitting your manuscript.
Manuscripts not conforming to these guidelines may be returned.
The Journal recommends that authors follow the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).
Sage is committed to upholding the integrity of the academic record. We encourage authors to refer to the Committee on Publication Ethics’ International Standards for Authors and view the author responsibilities section on the Sage Journal Author Gateway.
We also encourage you to familiarize yourself with our Editorial Policies and our Publication Ethics Policies.
Sage Publishing disseminates high-quality research and engaged scholarship globally, and we are committed to diversity and inclusion in publishing. We encourage submissions and peer review from a diverse range of authors and reviewers from across all countries and backgrounds. Read our diversity, equity, and inclusion pledge.
Please read the guidelines below then submit your manuscript here.
Access: Open Access
APC: See article processing charge information below
Accepts preprints? Yes
Identity transparency: Single anonymized
Please note that this journal is online-only and does not offer print copies.
Journal of Alzheimer's Disease Reports is an open access, peer-reviewed journal. All accepted articles are made freely available online immediately upon publication, are published under a Creative Commons license, and hosted online in perpetuity.
If, after peer review, your manuscript is accepted for publication, a one-time article processing charge (APC) is payable to cover the cost of publishing, paid by the funder, institution, or author. There is no charge for submitting a manuscript.
The article processing charge (APC) is $3000 .
The article processing charge (APC) is payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Tax-exempt status can be indicated by providing appropriate registration numbers when payment is requested. Please see further details on tax-exempt status here.
For general information on open access at Sage please visit the Open Access page.
Authors may be eligible for discounts to their APC via open access agreements that Sage has with participating institutions. Discounts depend on the terms of the agreement, find out if your institution is participating by visiting Open Access Agreements at Sage. Eligibility is determined by the corresponding author’s affiliation at acceptance matching an agreement.
Your article may be eligible for a full or partial waiver due to our participation in initiatives to increase accessibility to publication across the international academic community. More information about discounts and eligibility.
Your article must be within the scope of the journal and be of sufficient quality. If not, it will not be reviewed. Please read the journal’s Aims and Scope to see if your article is appropriate.
The manuscript must be your original work, you must have the rights to the work, and you must have obtained and be able to supply all necessary permissions for the reproduction of any copyright works not owned by you, including figures, illustrations, tables, lengthy quotations, or other material previously published elsewhere.
Research Articles
Organization and style of presentation
⦁ Manuscripts must be written in English. Authors whose native language is not English are advised to consult a professional English language editing service or a native English speaker prior to submission.
⦁ Manuscripts should make it clear how the work is relevant to Alzheimer's disease and within the scope of JAD. Be sure to include "Alzheimer's disease" in both the abstract and keywords.
⦁ Nomenclature for amyloids should follow the 2018 guidelines of the International Society of Amyloidosis (ISA) nomenclature committee (Amyloid 25, 215-219, 2018), e.g., amyloid-β (Aβ) and amyloid-β protein precursor (AβPP). Also preferred is Aβ42 and sAβPPα.
⦁ Manuscripts should be double spaced throughout with wide margins (2.5 cm or 1 in), including the abstract and references, with line numbers. Every page of the manuscript, including the title page, references, tables, etc., should include a page number centered at the bottom. Do not number headings or subheadings (use bold with initial cap; then italic with initial cap; then italic with initial cap and full stop/period with text following directly after). Footnotes should be avoided.
⦁ There are no page or word limits for Research Articles, Systematic Reviews, Hypotheses, or Review Articles but manuscripts over 10,000 words (Introduction through Discussion) should be approved by the Editor-in-Chief before submission.
⦁ Abbreviations should be defined at first use and avoided if not used more than 3 times. We do not typically include abbreviation lists in published manuscripts.
Each Research Article should include the following sections: Structured abstract (250 words or less), Introduction, Methods, Results, and Discussion
Reviews
Reviews (narrative) should be authoritative and topical and provide comprehensive and balanced coverage of a timely and/or controversial issue. Reviews should include an unstructured abstract (250 words or less) and a conclusion. The length of the review article is at the discretion of the author but should be within reasonable limits. The Editor-in-Chief can be consulted regarding reviews over 10,000 words.
Systematic reviews/Meta-analyses
These types of articles that include a methods section should be formatted as a Research article (Structured abstract, Introduction, Methods, Results, and Discussion). They should follow Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines and include the latest PRISMA checklist as supplemental material for review only.
Short Communications
A short communication is an article of original scholarship of unusual interest of less than 2000 words (Introduction through Discussion only; do not include abstract, declarations, references, tables, or figures/legends). An unstructured abstract of 100 words or less should be included with no subdivison of the abstract into sections. A total of three tables and/or figures are allowed. Submissions that exceed the word or figure/table limits will be considered a Research Article. Supplementary Material for Short Communications is limited to 500 words and 1 table or figure.
Hypotheses
A hypothesis article should be a balanced and insightful consideration of a topic with novel hypotheses well-presented and supported. An unstructured abstract of 250 words or less is required.
Clinical Trial Protocols
Clinical Trial Protocol articles should contain the study’s trial registration number and date of registration (mandatory), objectives, design, and methods including subject target and/or enrollment criteria. It can also include relevant scientific background and statistical information. Protocols should be submitted well before recruitment completes. Protocols for pilot or feasibility studies are not usually considered. Authors are required to include the results of the pilot as part of the protocol article. Protocols of randomized trials should follow the SPIRIT guidelines, including the SPIRIT flow diagram in the main body of the text, with the populated checklist provided as an additional file. All protocols for clinical trials must have a trial registration number and date of registration (mandatory) included as the last line of the abstract. Protocol submissions should be formatted as a Research Article omitting the “Results” section from both the abstract and the main body. Be sure to include the trial registration number and date of registration at the end of the abstract and include ethics approval and consent to participate in the methods section. All other sections and requirements/statements for a Research Article should be included.
Commentaries
Commentaries are usually commissioned and of around 1000 words with a short, unstructured abstract (100 words or less) and no other subdivisions. A commentary is a short work written to discuss, prove, clarify, support, improve, or dispute a published (or soon to be published) article. A commentary typically does not include original data and discusses specific issues within a subject area rather than the whole field, explains the implications of the article, and/or puts it in context. Include an original title for your commentary (do not title it "Commentary on 'Article title'"). If relevant, be sure to include a citation/reference to the article you are commenting on (even if "in press").
Editorials
Editorials are usually around 1000 words with a short abstract (100 words or less) and no other subdivisions. Include References and Statements/Declarations as required for all submissions.
Case Reports
A case report is typically less than 2000 words (Introduction through Conclusion) and should include: Unstructured abstract (100 words or less); Introduction; Case Presentation; Discussion; and Conclusion. Include References and Statements/Declarations as required for all submissions.
The journal endorses the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first participant enrollment. However, consistent with the AllTrials campaign, retrospectively registered trials will be considered if the justification for late registration is acceptable. The trial registry name and URL, and registration number must be included at the end of the abstract.
If your research involves animals, you will be asked to confirm that you have carefully read and adhered to the ARRIVE guidelines.
The preferred format for your manuscript is Word. You do not need to follow a template, but please ensure your heading levels are clear, and the sections clearly defined.
Your article title, keywords, and abstract all contribute to its position in search engine results, directly affecting the number of people who see your work. For details of what you can do to influence this, visit How to help readers find your article online.
Your manuscript’s title should be concise, descriptive, unambiguous, accurate, and reflect the precise contents of the manuscript. A descriptive title that includes the topic of the manuscript makes an article more findable in the major indexing services.
Author listing
For research articles and systematic reviews/meta-analyses, please include a structured abstract (Background, Objective, Methods, Results, Conclusions) of 250 words between the title and main body of your manuscript that concisely states the purpose of the research, major findings, and conclusions. If your research includes clinical trials, the trial registry name and URL, and registration number must be included at the end of the abstract. Submissions that do not meet this requirement will not be considered.
For clinical trials, the trial registry name and URL, and registration number must be included at the end of the abstract.
For other full-length papers such as reviews and hypotheses, the abstract is unstructured and should be clear, descriptive, and self-explanatory, and no longer than 250 words. Abstracts for short communications, commentaries, and editorials should be 100 words or less.
Please include a minimum of 4 keywords, listed after the abstract. These keywords should be terms from the MeSH database.
For guidance on the preparation of illustrations, pictures, and graphs in electronic format, please read Sage’s artwork guidelines.
Figures supplied in color will appear in color online.
Please ensure that you have obtained any necessary permission from copyright holders for reproducing any illustrations, tables, figures, or lengthy quotations previously published elsewhere. For further information including guidance on fair dealing for criticism and review, please see the Frequently Asked Questions page on the Sage Journal Author Gateway.
If you are including an Acknowledgements section, this will be published at the end of your article. The Acknowledgments section should include all contributors who do not meet the criteria for authorship. Per ICMJE recommendations, it is best practice to obtain consent from non-author contributors who you are acknowledging in your manuscript.
Writing assistance and third party submissions: if you have received any writing or editing assistance from a third-party, for example a specialist communications company, this must be clearly stated in the Acknowledgements section and in the covering letter. Please see the Sage Author Gateway for what information to include in your Acknowledgements section. If your submission is being made on your behalf by someone who is not listed as an author, for example the third-party who provided writing/editing assistance, you must state this in the Acknowledgements and also in your covering letter. Please note that the journal editor reserves the right to not consider submissions made by a third party rather than by the author/s themselves.
As part of our commitment to ensuring an ethical, transparent and fair peer review and publication process, this journal has adopted CRediT (Contributor Roles Taxonomy). CRediT is a high-level taxonomy, including 14 roles, which is used to describe each author’s individual contributions to the work.
You will be asked to list the contribution of each author as part of the submission process. Please include the Author Contributions heading within your submission after the Acknowledgements section. The information you give on submission will then show under the Author Contributions heading later at the proofing stage.
Please include a section with the heading ‘Statements and Declarations’ at the end of your submitted article, after the Acknowledgements section [and Author Contributions section if applicable] including each of the sub-headings listed below. If a declaration is not applicable to your submission, you must still include the heading and state ‘Not applicable’ underneath. Please note that you may be asked to justify why a declaration was not applicable to your submission by the Editorial Office.
Please include your ethics approval statements under this heading, even if you have already included ethics approval information in your methods section. If ethical approval was not required, you need to explicitly state this. You can find information on what to say in your ethical statements as well as example statements on our Publication ethics and research integrity policies page.
All papers reporting studies involving human participants, human data or human tissue must state that the relevant Ethics Committee or Institutional Review Board approved the study, or waived the requirement for approval, providing the full name and institution of the review committee in addition to the approval number If applicable, please also include this information in the Methods section of your manuscript.
Please include any participant consent information under this heading and state whether informed consent to participate was written or verbal. If the requirement for informed consent to participate has been waived by the relevant Ethics Committee or Institutional Review Board (i.e. where it has been deemed that consent would be impossible or impracticable to obtain), please state this. If this is not applicable to your manuscript, please state ‘Not applicable’ in this section. More information and example statements can be found on our Publication ethics and research integrity policies page.
Submissions containing any data from an individual person (including individual details, images or videos) must include a statement confirming that informed consent for publication was provided by the participant(s) or a legally authorized representative. Non-essential identifying details should be omitted. Please do not submit the participant’s actual written informed consent with your article, as this in itself breaches the patient’s confidentiality. The Journal requests that you confirm to us, in writing, that you have obtained written informed consent to publish but the written consent itself should be held by the authors/investigators themselves, for example in a patient’s hospital record. The confirmatory letter may be uploaded with your submission as a separate file in addition to the statement confirming that consent to publish was obtained within the manuscript text.If this is not applicable to your manuscript, please state ‘Not applicable’ in this section.
The journal requires a declaration of conflicting interests from all authors so that a statement can be included in your article. For guidance on conflict of interest statements, see our policy on conflicting interest declarations and the ICMJE recommendations.
If no conflict exists, your statement should read: ‘The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article’.
All articles need to include a funding statement, under a separate heading, even if you did not receive funding. You’ll find guidance and examples on our Funding page.
The Journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the Sage Research Data policy pages.
Subject to appropriate ethical and legal considerations, authors are encouraged to:
The journal follows the Sage Vancouver reference style. View the Sage Vancouver guidelines to ensure your manuscript conforms.
Every in-text citation must have a corresponding citation in the reference list and vice versa. Corresponding citations must have identical spelling and year.
Authors should update any references to preprints when a peer reviewed version is made available, to cite the published research. Citations to preprints are otherwise discouraged.
If you use EndNote to manage references, you can download the Sage Vancouver EndNote output file
This Journal can host additional materials online (e.g. datasets, podcasts, videos, images etc.) alongside the full text of the article. Your supplemental material must be one of our accepted file types. For that list and more information please refer to our guidelines on submitting supplemental files.
Authors seeking assistance with English language editing, translation, or figure and manuscript formatting to fit the journal’s specifications should consider using Sage Author Services. Visit Sage Author Services for further information.
As part of the submission process you will need to confirm that this is your original work, that you have the rights in the work, that this is for first publication in this Journal, that it is not being considered for/has not already been published elsewhere, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you.
Please see our guidelines on prior publication and note that the journal may accept submissions of manuscripts that have been posted on preprint servers.
The journal will consider submissions of manuscripts that have been posted on preprint servers.
Please enter the preprint DOI in the designated field when submitting your manuscript. We advise that you inform the Journal Editorial office about your posted preprint at submission.
Note that you should not post an updated version of your manuscript on a preprint server while it is being peer reviewed.
Submit your manuscript online via Sage Track.
IMPORTANT: Please check whether you already have an account in Sage Track before trying to create a new one. If you have reviewed or authored for the journal in the past year it is likely that you will have had an account created. For further guidance on submitting your manuscript online please visit ScholarOne Online Help.
Manuscripts should only be submitted with the consent of all contributing authors. The individual responsible for submitting the manuscript should carefully check that all those whose work contributed to the manuscript are listed as authors.
Ensure you upload all relevant manuscript files, including any additional supplemental files (including reporting guidelines where relevant).
Please view our authorship policies, which includes information on criteria for authorship, who should be the corresponding author and more.
Please note that AI chatbots, for example ChatGPT, should not be listed as authors. For more information see the policy on Use of ChatGPT and generative AI tools.
The following summary describes the peer review process for this journal:
Identity transparency: Single-anonymized
Reviewer interacts with: Editor
Review information published: None
Your manuscript will undergo an initial evaluation. If it does not conform to the requirements laid out in these guidelines, it will be returned to you for amendments prior to peer review. Manuscripts may be desk rejected without peer review at this point if they are out of scope for the journal or otherwise unsuitable.
After passing the initial evaluation, your manuscript will then be peer reviewed. You can log in at any time to check the status of your manuscript. We will notify you when a decision has been reached.
The journal operates a conventional single-anonymized reviewing policy in which the reviewer’s name is always concealed from the submitting author.
To ensure the integrity of the peer review process we assign reviewers and cannot accept author recommendations.
All manuscripts are reviewed as rapidly as possible, while maintaining rigor. The authors may identify an Associate Editor with expertise in the area of the study (if no Associate Editor is suitable, the Editorial Office will handle the submission). No authors of a submission can serve as the Handling Associate Editor of that same submission. Additionally, an Associate Editor who has collaborated with the authors in the past three years cannot serve as the Handling Associate Editor. The Associate Editor will be responsible for identifying reviewers and, after receiving reviews, for making a recommendation on the acceptability of the manuscript for publication. All final decisions on acceptability will be made by the Editor-in-Chief. The Associate Editors will be listed in the article as the Handling Associate Editor.
Reviewers make comments to the author and recommendations to the Editor who then makes the final decision on all manuscripts, including those appearing in a special issue or special collection. The Editor or members of the Editorial Board may occasionally submit their own manuscripts for possible publication in the Journal. In these cases, the peer review process will be managed by alternative members of the Board and the submitting Editor/Board member will have no involvement in the decision-making process.
As a COPE member we engage with multiple forms of post-publication discussion in line with wider guidance from Sage: Commentaries, Critiques and Responses.
You can view our complaints and appeals policy here.
Read Sage's complete peer review policy.
The journal and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. Please read Sage's complete policy on plagiarism and the actions we may take.
After acceptance you will receive instructions via email inviting you to complete the Open Access process. This will include signing the appropriate Creative Commons license and, where applicable, paying the Article Processing Charge (APC) or assigning a bill payer. Once the APC has been processed, your article will be prepared for publication and can appear online within an average of 30 days. Please note that, where an APC is applicable, production work cannot be completed on your manuscript until payment has been received.
Before publication we require the author as the rights holder to sign a Journal Contributor’s Publishing Agreement. The journal publishes manuscripts under Creative Commons licenses. The standard license for the journal is Creative Commons by Attribution Non-Commercial (CC BY-NC), which allows others to re-use the work without permission as long as the work is properly referenced and the use is non-commercial. For more information, you are advised to visit Sage's OA licenses page. Alternative license arrangements are available at the author’s request (e.g. to meet particular funder mandates).
If your manuscript was posted on a preprint server prior to acceptance, you must include a link in your preprint to the final published version of your published article.
Your Sage Production Editor will keep you informed as to your article’s progress throughout the production process. Proofs will be made available to the corresponding author via our editing portal, Sage Edit, or by email, and should be returned promptly to avoid delaying publication. Authors are reminded to check their proofs carefully to confirm that all author information, including names, affiliations, sequence, and contact details are correct, and that Funding and Conflict of Interest statements, if any, are accurate. This is the final opportunity to make changes to your manuscript. Further corrections will not be possible after publication. Changes to the author list are not permitted at this stage.
Publication is not the end of the process. Between us, we can ensure that your article is found, read, downloaded and cited as widely as possible. Many of the most effective tactics are those you can do quickly and easily to your network of contacts and peers. Visit the Promote Your Article page on the Sage Journal Author Gateway for numerous resources to help you promote your work.
The Sage Journal Author Gateway has some general advice on how to get published, plus links to further resources. Sage Author Services also offers authors a variety of ways to improve and enhance your article including English language editing, plagiarism detection, and video abstract and infographic preparation.
If you have any questions about publishing with Sage, please visit the Sage Journals Solutions Portal.
You can view our complaints and appeals procedure.
You can direct any questions to the journal’s editorial office:
Beth Kumar
Managing Editor
Email:
jadreports@iospress.com